During the past decade, North Texas Institute of Neurology and Headache conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Texas Institute of Neurology and Headache" #1 sponsor was "Pfizer" with 4 trials, followed by "Revance Therapeutics, Inc." with 2 trials sponsored, "Amgen" with 1 trials sponsored, "H. Lundbeck A/S" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "North Texas Institute of Neurology and Headache" are "Migraine" (4 trials), "Upper Limb Spasticity" (2 trials), "Acute Treatment of Migraine" (1 trials), "Migraine in Children" (1 trials) and "Pediatric Migraine" (1 trials). Many other conditions were trialed in "North Texas Institute of Neurology and Headache" in a lesser frequency.

Most popular intervention types in "North Texas Institute of Neurology and Headache" are "Drug" (6 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AboBoNT-A" (1 trials), "BHV-3500 (zavegepant)" (1 trials), "DAXI for Injection: HIGH Dose" (1 trials) and "DAXI for Injection: LOW Dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Texas Institute of Neurology and Headache" are 9 trials for "All" genders.

Currently, there are NaN active trials in "North Texas Institute of Neurology and Headache". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in North Texas Institute of Neurology and Headache, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in North Texas Institute of Neurology and Headache, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".